MRD Status Helped Predict Outcomes in CLL Responders

The quantification of a patient ’s MRD after treatment for CLL allowed for a more specific prediction of progression-free survival among patients who responded to treatment.

Source: CancerNetwork - September 5, 2016 Category: Cancer & Oncology Authors: Leah Lawrence Tags: Hematologic Malignancies Leukemia & Lymphoma News Source Type: news